CLINICAL_TRIALS
trial_result
· 2022-11-16
Clinical Trial Update: Adult Growth Hormone Deficiency and Cardiovascular Risk [Phase 4]
Summary
Phase 4 clinical trial update on adult growth hormone deficiency and cardiovascular risk; study terminated with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Columbia University | Conditions: Growth Hormone Deficiency | Phase 4 | Status: TERMINATED | Results posted: 2022-11-16